Be A Biotech Value Investor (Start With 2 Stocks!)
You can find value in the most unlikely places. Biotech is one of my go-to sources for winning investments. As I’ve written before, genomics (aka…
Biotech
Best Stocks To Buy This Week? 3 Biotech Names To Know
3 Biotech Stocks To Check Out This Week The broader stock market appears to be taking a breather after a mostly hot week fueled by…
Biotech Buys: 2 Top Picks Under $10
As a result of the pandemic, investors have likely become familiar with a number of biotech names over the past year and a half that…
COVID & Non-COVID, 3 Biotech Stocks To Watch
Against a backdrop in which investors remain keen on COVID-19 vaccine stocks such as Moderna and Novavax, and in which Biogen has just received the…
Analysts See More Than 60% Upside For These 4 Biotech Stocks
“Now that the global vaccination drive is in full flight, biotech companies are working on their research and development projects to advance new therapies to…
A Recently Approved Label Expansion Could Expand This Pain Management Stock’s Horizons
Amid the ongoing opioid crisis, the need for non-opioid pain management solutions is increasing. As a provider of pre- and post-surgical non-opioid pain management solutions,…
These Biotech Stocks Could Get “Let Out Of The Cage” This Year
“Few areas in equities are more volatile than small-cap biotech, biopharma and health care. Combined, these sectors produce more massive winners and horrid losers than…
5 Health Care Stocks That Could Be Top Performers In 2021
Today’s article highlights five health care stocks that analysts believe could be top performers in 2021, with the author advising that “While certainly not as…
Treating Severe COVID-19 Could Be Just “The Tip Of The Iceberg” For This Biotech Up 38,000%
The small Swiss biotech firm featured in today’s article has been developing a drug that could help patients suffering from severe COVID-19 – and with…
Is The Stage Being Set For A Strong Biotech Rally?
Amid setbacks for various potential COVID-19 vaccines and treatments, election risk, strengthening M&A activity, and more, what’s the outlook for healthcare and biotech in the…